HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adhesion molecules close homolog of L1 and tenascin-C affect blood-spinal cord barrier repair.

Abstract
Mice deficient in the recognition molecules, close homolog of L1 (CHL1) and tenascin-C, show improved and reduced functional recovery, respectively, after spinal cord injury compared with wild-type littermates. In this study, we addressed the question whether the differential functional outcome was paralleled by differences in blood-spinal cord barrier (BSCB) repair in the two mouse strains. We conducted spinal cord compression injuries in knock-out and wild-type mice. BSCB permeability was assessed by measuring the Evans blue spread within the spinal cord tissue at 14-21 days after injury. Results show that CHL1 reduces and tenascin-C enhances BSCB permeability, suggesting a correlation between functional outcome and BSCB repair.
AuthorsNicole R Peter, Ronak T Shah, Jian Chen, Andrey Irintchev, Melitta Schachner
JournalNeuroreport (Neuroreport) Vol. 23 Issue 8 Pg. 479-82 (May 30 2012) ISSN: 1473-558X [Electronic] England
PMID22473292 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Adhesion Molecules
  • Chl1 protein, mouse
  • Tenascin
  • Evans Blue
Topics
  • Analysis of Variance
  • Animals
  • Cell Adhesion Molecules (deficiency, metabolism)
  • Disease Models, Animal
  • Evans Blue
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microvessels (drug effects, pathology, physiopathology)
  • Permeability
  • Recovery of Function (genetics)
  • Spinal Cord (metabolism)
  • Spinal Cord Injuries (pathology, physiopathology)
  • Spinal Cord Regeneration (genetics)
  • Tenascin (deficiency, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: